Results 21 to 30 of about 10,116 (213)

Treating the face of women with botulinum toxin type A: 7-year review [PDF]

Revista Brasileira de Cirurgia Plástica, 2023
Introduction: Botulinum toxin type A (BTX-A) is the number one aesthetic procedure worldwide, and the difficulty in standardizing the aesthetic treatment of the face results in a broad range of treatment possibilities.
Victor Hugo Lara Cardoso Sá, Pablo Eduardo Elias, Gerson Vilhena Pereira, Ethel Zimberg Chehter   +3 more
doaj   +1 more source

Botulinum Neurotoxins (BoNTs) and Their Biological, Pharmacological, and Toxicological Issues: A Scoping Review

Applied Sciences, 2021
Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini, Francesco Inchingolo, Gianna Dipalma, Angelika Elzbieta Wegierska, Ioannis Alexandros Charitos, Maria Assunta Potenza, Antonio Scarano, Felice Lorusso, Alessio Danilo Inchingolo, Monica Montagnani, Luigi Santacroce   +10 more
doaj   +1 more source

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials

Toxins, 2023
DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004).
Conor J. Gallagher, Ronald R. Bowsher, Amanda Clancy, Jeffrey S. Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik   +6 more
doaj   +1 more source

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

Arquivos de Neuro-Psiquiatria
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva   +4 more
doaj   +1 more source

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]

Investigative and Clinical Urology, 2020
After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj   +1 more source

Treatment of periorbital syringoma with intradermal botulinum toxin A monotherapy versus carbon dioxide laser: a case report [PDF]

Surgical & Cosmetic Dermatology
Syringomas are benign adnexal neoplasms that develop from eccrine sweat ducts. They are mostly found in early adulthood, with a female gender predominance. They typically occur on the face, particularly the periorbital region, which has a high demand for
Sheila Hustadi Budiawan, Abraham Arimuko, Lilik Norawati, Asnawi Madjid, Widya Widita   +4 more
doaj   +1 more source

Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update

Toxins
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho, Moises Dominguez, Christopher L. Robinson, Sait Ashina   +3 more
doaj   +1 more source

The positive effect of Botulinum toxin type A on the viability of random flap in tobacco exposed in rats [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE: To evaluate the effect of Botulinum Toxin A in different time of tobacco exposure. METHODS: 60 male, Wistar rats were divided into two tobacco exposure groups: a 2- month or a 4-month regimen.
Cristina Pires Camargo, Felipe Alexandre Fernandes, Michel Hyo Mi Lee, Luiza Campos Moreira Silva, Julio Morais Besteiro, Rolf Gemperli   +5 more
doaj   +2 more sources

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis

Urology Research and Practice, 2023
Objective: This study aimed to evaluate retrospectively the outcomes of Abobotulinumtoxin-A (Dysport®) intravesical injection in refractory interstitial cystitis/ bladder pain syndrome patients to first- and second-line treatment.
Mohammad-Sajjad Rahnamai, Hanieh Salehi-Pourmehr, Sana Saeedi, Sona Tayebi, Sakineh Hajebrahimi   +4 more
doaj   +1 more source

Genetically Confirmed Schwartz–Jampel Syndrome: An Ultra-Rare Case of Congenital Myotonia with Osteochondrodysplasia from India

International Journal of Medical Students
Background: Schwartz–Jampel syndrome is a rare autosomal recessive disorder caused by mutations in the HSPG2 gene, leading to perlecan deficiency. Perlecan is a heparan sulfate proteoglycan critical for cartilage integrity, basement membrane stability ...
Nandita Jali, Suvarna Magar, Tanya Trikha, Varsha Vaidya, Viranchi Vaidya   +4 more
doaj   +1 more source